Loading viewer...
investor_presentation
Format: PDF investor_presentation
ViiV Healthcare presentation covering the company's vision, operating model, and HIV market position. Key focus on dolutegravir (DTG) portfolio and R&D strategy, delivered by CEO Dominique Limet and Chief Scientific and Medical Officer John Pottage.
investor_presentation
31 Pages
investor_presentation
15 Pages
Frontline
Adesto Technologies Investor Presentation — March 2017
investor_presentationinvestor_presentation
23 Pages
Adesto Technologies Corporation
Q2FY26 Investor Update
investor_presentationinvestor_presentation
JCurve Solutions
Footprint International SPAC Merger Presentation 2021
investor_presentationinvestor_presentation
62 Pages
Footprint International Holdco, Inc.